iQure Pharma Inc.

New Filing
CIK: 0001996977·Other·DELAWARE·Filed: Jan 16, 2025
Total Offering

$1,443,786

Amount Sold

$1,443,786

Investors

2

First Sale

Dec 20, 2024

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Pawel Zolnierczyk
Related Person

Company

iQure Pharma Inc.

3 KITTANSETT COURT

SKILLMAN, NJ, 08558

3122911382

SEC Filing

0001996977-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
iQure Pharma Inc. Form D Filing — $1,443,786 | FilingFlow